Hematologic Cancer

Lymphoma

Hoag offers leading expertise in lymphoma and blood cancers, delivered by a highly experienced multidisciplinary team supported by world-class diagnostics, molecular imaging, and nationally recognized specialists. Patients have access to advanced treatments including immunotherapy, chemotherapy, radiation therapy, precision medicine, and CAR-T cell therapy, one of the most innovative options available for relapsed or refractory disease.

Leukemia

A leukemia diagnosis can be overwhelming, and hard to understand. At Hoag Family Cancer Institute, we're committed to caring for body, mind and soul, helping patients navigate the process of healing with less confusion and more agency. From next-generation treatments to our dedicated clinical nurse navigators to help patients find resources and information, we're here for you.

Myelodysplastic Syndrome

A myelodysplastic syndrome diagnosis is news nobody wants to get, but Hoag is ready to help you understand your treatment options, mitigate symptoms and find your best path forward. Our whole-body approach brings together the best research, technology and treatment options along with a world-class team of physicians with one goal in mind: to see you as more than just a diagnosis, and help you see a future beyond your condition.

Myeloma

Hoag offers leading expertise in myeloma and blood cancers, delivered by a highly experienced multidisciplinary team supported by world-class diagnostics, molecular imaging, and nationally recognized specialists. Patients have access to advanced treatments including immunotherapy, chemotherapy, radiation therapy, precision medicine, and CAR-T cell therapy, one of the most innovative options available.

Myeloproliferative Neoplasms

Myeloproliferative neoplasms are very rare, with only around 20,000 total cases diagnosed in the U.S. each year according to the National Cancer Institute. As the highest-volume cancer center in Orange County, Hoag sees and treats more blood cancer cases, including rare types like myeloproliferative neoplasms.